Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 39 articles:
HTML format



Single Articles


    June 2024
  1. DI LEO L, Pagliuca C, Kishk A, Rizza S, et al
    AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.
    Proc Natl Acad Sci U S A. 2024;121:e2400566121.
    PubMed     Abstract available


    May 2024

  2. Correction for Ichimura et al., Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice.
    Proc Natl Acad Sci U S A. 2024;121:e2408646121.
    PubMed    


    April 2024
  3. ICHIMURA Y, Konishi R, Shobo M, Tanaka R, et al
    Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice.
    Proc Natl Acad Sci U S A. 2024;121:e2313070121.
    PubMed     Abstract available


  4. PIRES L, Khattak S, Pratavieira S, Calcada C, et al
    Femtosecond pulsed laser photodynamic therapy activates melanin and eradicates malignant melanoma.
    Proc Natl Acad Sci U S A. 2024;121:e2316303121.
    PubMed     Abstract available


  5. LEE KW, Ryu KJ, Kim M, Lim S, et al
    RCHY1 and OPTN are required for melanophagy, selective autophagy of melanosomes.
    Proc Natl Acad Sci U S A. 2024;121:e2318039121.
    PubMed     Abstract available


    January 2024
  6. BANUELOS A, Zhang A, Berouti H, Baez M, et al
    CXCR2 inhibition in G-MDSCs enhances CD47 blockade for melanoma tumor cell clearance.
    Proc Natl Acad Sci U S A. 2024;121:e2318534121.
    PubMed     Abstract available


  7. DUAN M, Song S, Wasserman H, Lee PH, et al
    High UV damage and low repair, but not cytosine deamination, stimulate mutation hotspots at ETS binding sites in melanoma.
    Proc Natl Acad Sci U S A. 2024;121:e2310854121.
    PubMed     Abstract available


    December 2023
  8. CHENG Q, Farbiak L, Vaidya A, Guerrero E, et al
    In situ production and secretion of proteins endow therapeutic benefit against psoriasiform dermatitis and melanoma.
    Proc Natl Acad Sci U S A. 2023;120:e2313009120.
    PubMed     Abstract available


    November 2023
  9. GUO D, Jurek R, Beaumont KA, Sharp DS, et al
    Invasion-Block and S-MARVEL: A high-content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasis.
    Proc Natl Acad Sci U S A. 2023;120:e2303978120.
    PubMed     Abstract available


  10. MAJI S, Pradhan AK, Kumar A, Bhoopathi P, et al
    MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.
    Proc Natl Acad Sci U S A. 2023;120:e2307094120.
    PubMed     Abstract available


    September 2023
  11. ZHANG X, Shi X, Zhang D, Gong X, et al
    Compression drives diverse transcriptomic and phenotypic adaptations in melanoma.
    Proc Natl Acad Sci U S A. 2023;120:e2220062120.
    PubMed     Abstract available


    August 2023
  12. CENTOFANTI E, Wang C, Iyer S, Krichevsky O, et al
    The spread of interferon-gamma in melanomas is highly spatially confined, driving nongenetic variability in tumor cells.
    Proc Natl Acad Sci U S A. 2023;120:e2304190120.
    PubMed     Abstract available


    July 2023
  13. MICEVIC G, Daniels A, Flem-Karlsen K, Park K, et al
    IL-7R licenses a population of epigenetically poised memory CD8(+) T cells with superior antitumor efficacy that are critical for melanoma memory.
    Proc Natl Acad Sci U S A. 2023;120:e2304319120.
    PubMed     Abstract available


    March 2023
  14. ZHOU J, Ma X, He X, Chen B, et al
    Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target.
    Proc Natl Acad Sci U S A. 2023;120:e2215732120.
    PubMed     Abstract available


    February 2023
  15. BASSEY-ARCHIBONG BI, Rajendra Chokshi C, Aghaei N, Kieliszek AM, et al
    An HLA-G/SPAG9/STAT3 axis promotes brain metastases.
    Proc Natl Acad Sci U S A. 2023;120:e2205247120.
    PubMed     Abstract available



  16. Correction for Dar et al., Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma.
    Proc Natl Acad Sci U S A. 2023;120:e2300251120.
    PubMed    


    January 2023
  17. BANNOUD N, Stupirski JC, Cagnoni AJ, Hockl PF, et al
    Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology.
    Proc Natl Acad Sci U S A. 2023;120:e2214350120.
    PubMed     Abstract available


    December 2022
  18. STOPFER LE, Rettko NJ, Leddy O, Mesfin JM, et al
    MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas.
    Proc Natl Acad Sci U S A. 2022;119:e2208900119.
    PubMed     Abstract available


    November 2022
  19. TOMASINA F, Martinez J, Zeida A, Chiribao ML, et al
    De novo sequencing and construction of a unique antibody for the recognition of alternative conformations of cytochrome c in cells.
    Proc Natl Acad Sci U S A. 2022;119:e2213432119.
    PubMed     Abstract available


    August 2022
  20. DAR AA, Bezrookove V, Nosrati M, Ice R, et al
    Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma.
    Proc Natl Acad Sci U S A. 2022;119:e2206824119.
    PubMed     Abstract available


  21. LIU X, Wang Y, Bauer AT, Kirschfink M, et al
    Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels.
    Proc Natl Acad Sci U S A. 2022;119:e2122716119.
    PubMed     Abstract available


    May 2022
  22. PHELPS GB, Hagen HR, Amsterdam A, Lees JA, et al
    MITF deficiency accelerates GNAQ-driven uveal melanoma.
    Proc Natl Acad Sci U S A. 2022;119:e2107006119.
    PubMed     Abstract available


    March 2022
  23. KAVRAN AJ, Stuart SA, Hayashi KR, Basken JM, et al
    Intermittent treatment of BRAF(V600E) melanoma cells delays resistance by adaptive resensitization to drug rechallenge.
    Proc Natl Acad Sci U S A. 2022;119:e2113535119.
    PubMed     Abstract available


  24. GUPTA A, Smith P, Bournazos S, Ravetch JV, et al
    A novel mouse strain optimized for chronic human antibody administration.
    Proc Natl Acad Sci U S A. 2022;119:e2123002119.
    PubMed     Abstract available


    February 2022
  25. AURORA AB, Khivansara V, Leach A, Gill JG, et al
    Loss of glucose 6-phosphate dehydrogenase function increases oxidative stress and glutaminolysis in metastasizing melanoma cells.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    January 2022
  26. KIM G, Wu Q, Chu JL, Smith EJ, et al
    Ultrasound controlled mechanophore activation in hydrogels for cancer therapy.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    October 2021
  27. GANGAEV A, Rozeman EA, Rohaan MW, Isaeva OI, et al
    Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    September 2021
  28. STOPFER LE, Gajadhar AS, Patel B, Gallien S, et al
    Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    June 2021
  29. ZHAO J, Jaffe A, Li H, Lindenbaum O, et al
    Detection of differentially abundant cell subpopulations in scRNA-seq data.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    May 2021
  30. YIN Q, Yu W, Grzeskowiak CL, Li J, et al
    Nanoparticle-enabled innate immune stimulation activates endogenous tumor-infiltrating T cells with broad antigen specificities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    April 2021
  31. YIN W, Li Y, Song Y, Zhang J, et al
    CCRL2 promotes antitumor T-cell immunity via amplifying TLR4-mediated immunostimulatory macrophage activation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  32. FALAHAT R, Berglund A, Putney RM, Perez-Villarroel P, et al
    Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    March 2021
  33. TENGESDAL IW, Menon DR, Osborne DG, Neff CP, et al
    Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    February 2021
  34. ZHANG H, You X, Wang X, Cui L, et al
    Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    December 2020
  35. PATUTINA OA, Gaponova Miroshnichenko SK, Sen'kova AV, Savin IA, et al
    Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.
    Proc Natl Acad Sci U S A. 2020;117:32370-32379.
    PubMed     Abstract available


  36. EISINGER S, Sarhan D, Boura VF, Ibarlucea-Benitez I, et al
    Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells.
    Proc Natl Acad Sci U S A. 2020;117:32005-32016.
    PubMed     Abstract available


    November 2020
  37. LU Y, Sandoval A, Voss S, Lai Z, et al
    Oncogenic allelic interaction in Xiphophorus highlights hybrid incompatibility.
    Proc Natl Acad Sci U S A. 2020;117:29786-29794.
    PubMed     Abstract available


    August 2020
  38. LI N, Kang Y, Wang L, Huff S, et al
    ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.
    Proc Natl Acad Sci U S A. 2020;117:20159-20170.
    PubMed     Abstract available


    June 2020
  39. LEX K, Maia Gil M, Lopes-Bastos B, Figueira M, et al
    Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish.
    Proc Natl Acad Sci U S A. 2020;117:15066-15074.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.